Thrombolex, Inc.

New Filing

CIK: 0001703764·Other Health Care·DELAWARE·Filed: Aug 30, 2022

Total Offering

$2,015,761

Amount Sold

$2,015,761

Investors

50

First Sale

Jul 28, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Michael J. Cerminaro	Related Person
Marvin Woodall	Related Person
Brian G. Firth	Related Person
Paul A. Stewart	Related Person
Todd Richmond	Related Person
John Cerminaro	Related Person

Company

Thrombolex, Inc.

4416 Route 27, Suite A

Kingston, NJ, 08528

8447926300

SEC Filing

0001703764-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.